DE60125191D1 - Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion - Google Patents

Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion

Info

Publication number
DE60125191D1
DE60125191D1 DE60125191T DE60125191T DE60125191D1 DE 60125191 D1 DE60125191 D1 DE 60125191D1 DE 60125191 T DE60125191 T DE 60125191T DE 60125191 T DE60125191 T DE 60125191T DE 60125191 D1 DE60125191 D1 DE 60125191D1
Authority
DE
Germany
Prior art keywords
compositions
methods
vitamins
cardiovascular function
improving cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60125191T
Other languages
English (en)
Other versions
DE60125191T2 (de
Inventor
L Butler
Cyr John St
A Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioenergy Inc
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/677,639 external-priority patent/US6429198B1/en
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of DE60125191D1 publication Critical patent/DE60125191D1/de
Application granted granted Critical
Publication of DE60125191T2 publication Critical patent/DE60125191T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60125191T 2000-07-28 2001-07-27 Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion Expired - Lifetime DE60125191T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22152600P 2000-07-28 2000-07-28
US221526P 2000-07-28
US09/677,639 US6429198B1 (en) 1999-04-12 2000-10-03 Compositions for increasing athletic performance in mammals
US677639 2000-10-03
US30220001P 2001-06-29 2001-06-29
US302200P 2001-06-29
PCT/US2001/041448 WO2002009727A1 (en) 2000-07-28 2001-07-27 Compositions and methods for improving cardiovascular function

Publications (2)

Publication Number Publication Date
DE60125191D1 true DE60125191D1 (de) 2007-01-25
DE60125191T2 DE60125191T2 (de) 2007-10-25

Family

ID=27396950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60125191T Expired - Lifetime DE60125191T2 (de) 2000-07-28 2001-07-27 Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion

Country Status (8)

Country Link
EP (1) EP1313488B1 (de)
JP (1) JP2004505056A (de)
CN (1) CN1299690C (de)
AT (1) ATE347896T1 (de)
AU (1) AU2001278197A1 (de)
DE (1) DE60125191T2 (de)
ES (1) ES2275703T3 (de)
WO (1) WO2002009727A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257591A1 (en) * 2002-08-30 2004-03-19 Mitsubishi Pharma Corporation Preventive and/or therapeutic agent for heart failure
JP5065570B2 (ja) * 2002-09-06 2012-11-07 第一三共ヘルスケア株式会社 血管内皮性酸化窒素の合成促進剤
JP2007106703A (ja) * 2005-10-14 2007-04-26 Nutri Kk 血管障害の予防および治療組成物
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
JPWO2007129618A1 (ja) * 2006-05-08 2009-09-17 国立大学法人 香川大学 好中球の活性化および遊走因子の抑制剤およびその利用
US8835396B2 (en) * 2006-12-15 2014-09-16 Bioenergy, Inc. Method and compositions for improving pulmonary hypertension
US9649334B2 (en) * 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
WO2009094593A1 (en) * 2008-01-25 2009-07-30 Foker John E Methods and compositions for inhibiting progression to chronic cardiac failure
JP5596779B2 (ja) * 2008-04-02 2014-09-24 バイオエナジー インコーポレイティド 急性心筋梗塞に対する初期対応におけるリボースの使用
IT1391588B1 (it) * 2008-10-15 2012-01-11 Giellepi Chemicals S P A Composizione sinergica per il recupero e la riduzione del danno ischemico lieve
GB201223365D0 (en) * 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
KR101666907B1 (ko) * 2014-12-16 2016-10-18 변종현 변성 타우린 및 이를 포함하는 대사질환 예방 또는 치료용 약학조성물
KR101666913B1 (ko) * 2014-12-23 2016-10-17 변종현 당 및 타우린을 포함하는 대사질환 예방 또는 치료용 약학조성물
CN109998101A (zh) * 2019-01-28 2019-07-12 天津星宇航天生物科技有限公司 一种适用心脏调养人群的宇航民用营养配方
CN110664824B (zh) * 2019-08-09 2021-01-01 北京佳博泰和健康科技有限公司 一种营养支持剂及其制备方法和用途
CN114209709A (zh) * 2021-12-16 2022-03-22 海门品尚医药科技有限公司 D-核糖在制备改善药物性心脏毒性药物或食品中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
JPH02286620A (ja) * 1989-04-27 1990-11-26 Riide Chem Kk 抗高脂血症用剤
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof

Also Published As

Publication number Publication date
CN1454090A (zh) 2003-11-05
JP2004505056A (ja) 2004-02-19
EP1313488B1 (de) 2006-12-13
AU2001278197A1 (en) 2002-02-13
EP1313488A1 (de) 2003-05-28
ATE347896T1 (de) 2007-01-15
CN1299690C (zh) 2007-02-14
ES2275703T3 (es) 2007-06-16
WO2002009727A1 (en) 2002-02-07
DE60125191T2 (de) 2007-10-25
EP1313488A4 (de) 2005-11-30

Similar Documents

Publication Publication Date Title
ATE347896T1 (de) Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion
EP2769715A3 (de) Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien
CY1110353T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
WO2006068697A3 (en) Compositions including iron
MX2007007781A (es) Composiciones cardiovasculares.
SG163600A1 (en) Methods for the treatment of muscle loss
ATE293974T1 (de) Pharmazeutische zusammensetzungen zur unbehagenverminderung
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2003038123A3 (en) Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
WO2005017192A3 (en) Screening for gestational disorders
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
EP2241196A3 (de) Oligosaccharide und Zysteine enthaltendes Nahrungsergänzungsmittel zur behandlung von hiv
BR0315169A (pt) Referência cruzada a pedidos de patente relacionados
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
WO2005058961A3 (en) Antibodies specific for human galanin, and uses thereof
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
PT1411960E (pt) Produto alimentar enriquecido a base de farelo de arroz para promocao da saude cardiovascular
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
ATE329601T1 (de) Medizinische zusammensetzungen zur behandlung oder vorbeugung eines funktionellen vitamin b12 mangels
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
SI1838716T1 (sl) Olanzapin pamoat dihidrat
BRPI0413618B8 (pt) xarope multivitamínico para crianças ou adolescentes
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition